BR112019005292A2 - anticorpos para siglec-15 e métodos de uso dos mesmos. - Google Patents

anticorpos para siglec-15 e métodos de uso dos mesmos.

Info

Publication number
BR112019005292A2
BR112019005292A2 BR112019005292A BR112019005292A BR112019005292A2 BR 112019005292 A2 BR112019005292 A2 BR 112019005292A2 BR 112019005292 A BR112019005292 A BR 112019005292A BR 112019005292 A BR112019005292 A BR 112019005292A BR 112019005292 A2 BR112019005292 A2 BR 112019005292A2
Authority
BR
Brazil
Prior art keywords
siglec
molecules
methods
antibodies
usually
Prior art date
Application number
BR112019005292A
Other languages
English (en)
Inventor
Benjamin Flies Dallas
Liu Linda
Langermann Solomon
Original Assignee
Nextcure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextcure Inc filed Critical Nextcure Inc
Publication of BR112019005292A2 publication Critical patent/BR112019005292A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

são fornecidas moléculas de ligação à siglec-15. as moléculas são normalmente um anticorpo ou seu fragmento de ligação a antígeno que se liga de forma imunoespecífica à siglec-15. são também fornecidas moléculas de ligação ao ligante de siglec-15. as moléculas são normalmente um polipeptídeo ou proteína de fusão de siglec-15. também são fornecidos métodos de uso das moléculas para reduzir a imunossupressão mediada por siglec-15 em um sujeito em necessidade.
BR112019005292A 2016-09-21 2017-09-21 anticorpos para siglec-15 e métodos de uso dos mesmos. BR112019005292A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662397794P 2016-09-21 2016-09-21
US201762451271P 2017-01-27 2017-01-27
US201762500578P 2017-05-03 2017-05-03
PCT/US2017/052714 WO2018057735A1 (en) 2016-09-21 2017-09-21 Antibodies for siglec-15 and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112019005292A2 true BR112019005292A2 (pt) 2019-09-03

Family

ID=65352347

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019005292A BR112019005292A2 (pt) 2016-09-21 2017-09-21 anticorpos para siglec-15 e métodos de uso dos mesmos.

Country Status (11)

Country Link
US (1) US11390675B2 (pt)
EP (1) EP3515478B1 (pt)
JP (3) JP7069177B2 (pt)
KR (2) KR20240035625A (pt)
CN (1) CN110035769A (pt)
AU (1) AU2017330346A1 (pt)
BR (1) BR112019005292A2 (pt)
CA (1) CA3033571A1 (pt)
DK (1) DK3515478T3 (pt)
RU (1) RU2759334C2 (pt)
WO (1) WO2018057735A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110035769A (zh) 2016-09-21 2019-07-19 奈斯科尔公司 针对siglec-15的抗体及其使用方法
CN110386982A (zh) * 2019-04-09 2019-10-29 广东三九脑科医院 鼠抗人Siglec-15蛋白单克隆抗体制备及其用途
US11104732B2 (en) * 2019-04-24 2021-08-31 Innovative Cellular Therapeutics Holdings, Ltd. Reducing immune inhibition induced by SIGLEC-15
MX2022011951A (es) * 2020-03-27 2023-03-06 Biosion Inc Anticuerpos de la lectina 15 similar a la inmunoglobulina que se une a acido sialico (siglec15) y usos de los mismos.
US20220017604A1 (en) * 2020-04-17 2022-01-20 Washington University ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES
EP4146704A2 (en) * 2020-05-06 2023-03-15 Dragonfly Therapeutics, Inc. Antibodies targeting clec12a and use thereof
CN113817057B (zh) * 2020-06-19 2024-02-20 盛禾(中国)生物制药有限公司 一种抗siglec15抗体及其应用
JP2023543896A (ja) * 2020-09-30 2023-10-18 エヌエー バイオテック コーポレイション 抗アデノシン受容体（Ａ２ａＲ）抗体
WO2022095934A1 (zh) * 2020-11-05 2022-05-12 上海津曼特生物科技有限公司 抗Siglec-15抗体及其在制备药物中的应用
US20240093149A1 (en) 2020-12-08 2024-03-21 Guizhou Sinorda Biotechnology CO., Ltd. Modified t cells for adoptive immunotherapy
CN114657132A (zh) * 2020-12-22 2022-06-24 未来智人再生医学研究院(广州)有限公司 一种表达Siglec-15靶向抑制因子的多能干细胞及其衍生物与应用
CN112625132B (zh) * 2021-01-15 2022-08-02 沈阳荣欣生物制药科技有限公司 纳米抗体及其编码基因、表达载体、宿主细胞和应用
ES2955819T3 (es) 2021-01-21 2023-12-07 Guizhou Sinorda Biotechnology Co Ltd Linfocitos T modificados para inmunoterapia adoptiva
CN114957468A (zh) 2021-02-25 2022-08-30 石药集团巨石生物制药有限公司 一种抗Siglec15抗体及其用途
CN112961214B (zh) * 2021-03-19 2022-08-02 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN112979761B (zh) * 2021-03-19 2021-12-10 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
WO2022228183A1 (zh) * 2021-04-30 2022-11-03 杭州邦顺制药有限公司 抗siglec15抗体及其制备方法和用途
WO2022237819A1 (zh) * 2021-05-13 2022-11-17 信达生物制药(苏州)有限公司 抗Siglec-15抗体及其用途
CN118043351A (zh) * 2021-08-31 2024-05-14 上海医药集团股份有限公司 靶向Siglec15的抗原结合蛋白及其用途
CN118159286A (zh) 2021-11-25 2024-06-07 正大天晴药业集团股份有限公司 抗Siglec-15抗体及其应用
WO2023163956A2 (en) * 2022-02-22 2023-08-31 Nextpoint Therapeutics, Inc. Kir3dl3 inhibitors and immune cell activating agents
CN114807052A (zh) * 2022-06-07 2022-07-29 江苏亲科生物研究中心有限公司 Siglec15单克隆抗体及其制备方法和用途
WO2023241538A1 (en) * 2022-06-13 2023-12-21 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Anti-siglec15 antibodies and uses thereof
CN117447594B (zh) * 2022-07-26 2024-06-25 北京东方百泰生物科技股份有限公司 一种抗Siglec-15单克隆抗体
WO2024022008A1 (zh) * 2022-07-26 2024-02-01 北京东方百泰生物科技股份有限公司 一种抗Siglec-15单克隆抗体、其抗原结合片段及其应用
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering
CN117430707B (zh) * 2023-10-25 2024-04-19 重庆天科雅生物科技有限公司 一种cik细胞的制备方法及其在治疗癌症中的用途
CN117645665B (zh) * 2024-01-29 2024-05-07 北京热景生物技术股份有限公司 一种针对α-突触核蛋白的抗体及其制备方法和应用

Family Cites Families (278)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4012112A (en) 1975-08-25 1977-03-15 Honeywell Inc. Microscope stage positioning system
US4063083A (en) 1976-04-21 1977-12-13 Wade Thomas Cathey Data communication system using light coupled interfaces
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4716111A (en) 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0149483A3 (en) 1984-01-16 1987-05-27 DeSOTO, INC. Coatings for magnetic recording structures
US4528364A (en) 1984-04-19 1985-07-09 The Dow Chemical Company Removal of alkaline catalysts from polyether polyols and polyalkylene carbonate polyols
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU607686B2 (en) 1985-11-25 1991-03-14 General Electric Company Crosslinkable polycyclic polycarbonate oligomers and methods for their preparation and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH0730154B2 (ja) 1986-04-08 1995-04-05 武田薬品工業株式会社 一液性熱硬化型樹脂組成物
EP0307434B2 (en) 1987-03-18 1998-07-29 Scotgen Biopharmaceuticals, Inc. Altered antibodies
JP2668534B2 (ja) 1987-10-06 1997-10-27 日本ポリウレタン工業 株式会社 押出成形、射出成形用熱可塑性ポリウレタン樹脂組成物
JP3095168B2 (ja) 1988-02-05 2000-10-03 エル． モリソン，シェリー ドメイン‐変性不変部を有する抗体
US5190929A (en) 1988-05-25 1993-03-02 Research Corporation Technologies, Inc. Cyclophosphamide analogs useful as anti-tumor agents
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US20030229208A1 (en) 1988-12-28 2003-12-11 Protein Design Labs, Inc. Humanized immunoglobulins
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
JPH03152181A (ja) 1989-11-09 1991-06-28 Teijin Chem Ltd 防曇性組成物
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
AU633698B2 (en) 1990-01-12 1993-02-04 Amgen Fremont Inc. Generation of xenogeneic antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
US5120727A (en) 1991-05-29 1992-06-09 American Home Products Corporation Rapamycin dimers
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
US5202332A (en) 1991-08-07 1993-04-13 American Home Products Corporation Rapamycin analog as immunosuppressant
US5162333A (en) 1991-09-11 1992-11-10 American Home Products Corporation Aminodiesters of rapamycin
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5766886A (en) 1991-12-13 1998-06-16 Xoma Corporation Modified antibody variable domains
GB9203459D0 (en) 1992-02-19 1992-04-08 Scotgen Ltd Antibodies with germ-line variable regions
US5714350A (en) 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
WO1993019763A1 (en) 1992-03-30 1993-10-14 American Home Products Corporation Rapamycin formulation for iv injection
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
DK0656946T4 (da) 1992-08-21 2010-07-26 Univ Bruxelles Immunoglobuliner uden lette kæder
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
CH686365A5 (de) 1992-10-06 1996-03-15 Werner Hofliger Mobilkran.
US5434260A (en) 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
EP0752248B1 (en) 1992-11-13 2000-09-27 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5441050A (en) 1992-12-18 1995-08-15 Neoprobe Corporation Radiation responsive surgical instrument
AU6796094A (en) 1993-04-29 1994-11-21 Raymond Hamers Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of (camelidae)
US5387680A (en) 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
AU689153B2 (en) 1993-11-08 1998-03-26 Cressy, Wayne Malcolm Head restraining device
US5385908A (en) 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
ATE191218T1 (de) 1993-12-17 2000-04-15 Novartis Ag Rapamycin-derivate als immunosuppressoren
JPH0880672A (ja) 1994-07-15 1996-03-26 Honshu Paper Co Ltd 感熱記録体
JPH08194162A (ja) 1995-01-17 1996-07-30 Nikon Corp ステージの駆動装置
EP1978033A3 (en) 1995-04-27 2008-12-24 Amgen Fremont Inc. Human antibodies derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5659421A (en) 1995-07-05 1997-08-19 Neuromedical Systems, Inc. Slide positioning and holding device
CA2188503A1 (en) 1995-12-22 1997-06-23 Neil H. Nodelman Polyurethane resin transfer molding systems
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
DE19619237A1 (de) 1996-05-13 1997-11-20 Bayer Ag Hydroxyfunktionelle Polyurethancarbonate, ein Verfahren zu deren Herstellung und deren Verwendung
US5856372A (en) 1996-05-23 1999-01-05 Arco Chemical Technology, L.P. Microcellular elastomers with improved processability and properties
US5779203A (en) 1996-06-28 1998-07-14 Edlinger; Erich Adjustable wafer cassette stand
JPH1036474A (ja) 1996-07-17 1998-02-10 Sanyo Chem Ind Ltd 膜モジュールのシール材用ポリウレタン樹脂形成性組成物
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
WO1998023289A1 (en) 1996-11-27 1998-06-04 The General Hospital Corporation MODULATION OF IgG BINDING TO FcRn
CA2616914C (en) 1996-12-03 2012-05-29 Abgenix, Inc. Egfr-binding antibody
US6277375B1 (en) 1997-03-03 2001-08-21 Board Of Regents, The University Of Texas System Immunoglobulin-like domains with increased half-lives
US7411051B2 (en) 1997-03-07 2008-08-12 Human Genome Sciences, Inc. Antibodies to HDPPA04 polypeptide
US5989591A (en) 1997-03-14 1999-11-23 American Home Products Corporation Rapamycin formulations for oral administration
CZ294425B6 (cs) 1997-04-14 2005-01-12 Micromet Ag Způsob výroby anti-humánního antigenového receptoru, anti-humánní antigenový receptor, řetězec VH a VL, souprava pro selekci anti-humánních antigenových receptorů a farmaceutická kompozice, obsahující uvedený receptor
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
EP0896013A1 (en) 1997-08-06 1999-02-10 Shimadzu Corporation Crosslinked polycarbonate and polylactic acid composition containing the same
US5936047A (en) 1997-08-18 1999-08-10 General Electric Company Molecular weight control
US5843597A (en) 1997-12-01 1998-12-01 Eveready Battery Company, Inc. Ribbed gasket for miniature galvanic cell
US6982323B1 (en) 1997-12-23 2006-01-03 Alexion Pharmaceuticals, Inc. Chimeric proteins for diagnosis and treatment of diabetes
EP1068241B1 (en) 1998-04-02 2007-10-10 Genentech, Inc. Antibody variants and fragments thereof
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
GB9814640D0 (en) 1998-07-06 1998-09-02 Fujisawa Pharmaceutical Co New use
US6015809A (en) 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
US6311415B1 (en) 1998-09-14 2001-11-06 Lind Shoe Company Bowling shoe with replaceable tip
KR100940380B1 (ko) 1999-01-15 2010-02-02 제넨테크, 인크. 효과기 기능이 변화된 폴리펩티드 변이체
US6046301A (en) 1999-04-12 2000-04-04 Bayer Corporation Polycarbonate compositions having reduced tendency to splay
US6395554B1 (en) 1999-09-03 2002-05-28 Packard Instrument Company Microarray loading/unloading system
JP3524509B2 (ja) 2000-04-27 2004-05-10 三洋化成工業株式会社 注型用ポリウレタン樹脂形成性組成物
CN1349096A (zh) 2000-10-13 2002-05-15 聿新科技股份有限公司 电化学电极试片及其制造方法
DE10061067C1 (de) 2000-12-08 2002-06-06 Bayer Ag Kontinuierliches Verfahren zur Herstellung von thermoplastisch verarbeitbaren Polyurethanelastomeren mit definiertem und standardisiertem Schmelze-Fließ-Verhalten und hoher Thermostabilität
AUPR376101A0 (en) 2001-03-15 2001-04-12 Vision Biosystems Limited Slide holder for an automated slide loader
JP4759154B2 (ja) 2001-03-22 2011-08-31 帝人株式会社 ポリカーボネート組成物およびその製造方法
DE10138216A1 (de) 2001-08-03 2003-02-20 Bayer Ag Aliphatische Polycarbonathomo- und -copolymere durch DMC-Katalyse
US7140655B2 (en) 2001-09-04 2006-11-28 Multimetrixs Llc Precision soft-touch gripping mechanism for flat objects
JP2003147070A (ja) 2001-11-12 2003-05-21 Shigeru Tasaka 機能性オリゴマーおよびその製造方法
JP2003147185A (ja) 2001-11-15 2003-05-21 Teijin Ltd 芳香族ポリカーボネート組成物、成形物および成形方法
US7390885B2 (en) * 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
JP2003183405A (ja) 2001-12-14 2003-07-03 Teijin Ltd 粉体ポリカーボネートおよびポリカーボネート粉体組成物
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
JP2003192761A (ja) 2001-12-27 2003-07-09 Mitsubishi Chemicals Corp アクリル変性ウレタン樹脂組成物及びその製造方法
US7098274B2 (en) 2002-08-27 2006-08-29 Acushnet Company Compositions for golf equipment
JP3985264B2 (ja) 2002-02-22 2007-10-03 日本ポリウレタン工業株式会社 高官能ポリカーボネートポリオールの製造方法
US7271006B2 (en) 2002-04-26 2007-09-18 Ventana Medical Systems, Inc. Method and apparatus for automated coverslipping
IL149820A0 (en) 2002-05-23 2002-11-10 Curetech Ltd Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
FI2206517T3 (fi) 2002-07-03 2023-10-19 Ono Pharmaceutical Co Immuunopotentioivia koostumuksia käsittäen anti-PD-L1 -vasta-aineita
JP3741085B2 (ja) 2002-07-03 2006-02-01 日立化成工業株式会社 光硬化性樹脂組成物
US7052694B2 (en) 2002-07-16 2006-05-30 Mayo Foundation For Medical Education And Research Dendritic cell potentiation
FR2844455B1 (fr) 2002-09-13 2007-12-14 Lab Francais Du Fractionnement Traitement des pathologies echappant a la reponse immune par des anticorps optimises
FR2844513B1 (fr) 2002-09-13 2007-08-03 Lab Francais Du Fractionnement Anticorps pour adcc et induisant la production de cytokines.
DK2345671T3 (en) 2002-09-27 2016-02-15 Xencor Inc Optimized Fc variants and methods for their formation
WO2004056875A1 (en) 2002-12-23 2004-07-08 Wyeth Antibodies against pd-1 and uses therefor
US7355008B2 (en) 2003-01-09 2008-04-08 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US7960512B2 (en) 2003-01-09 2011-06-14 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US7241504B2 (en) 2003-01-17 2007-07-10 The United States Of America As Represented By The Secretary Of The Navy Diols formed by ring-opening of epoxies
KR20050107399A (ko) 2003-01-23 2005-11-11 오노 야꾸힝 고교 가부시키가이샤 인간 ｐｄ-1에 대하여 특이성을 갖는 물질
EP1608400B1 (en) 2003-03-28 2010-06-23 Faron Pharmaceuticals OY Elevation of adenosine level by cytokine-induced expression of cd73
KR101861493B1 (ko) 2003-04-11 2018-05-28 가부시키가이샤 니콘 액침 리소그래피 머신에서 웨이퍼 교환동안 투영 렌즈 아래의 갭에서 액침 액체를 유지하는 장치 및 방법
KR101178959B1 (ko) 2003-09-12 2012-08-31 바스프 에스이 고작용성의, 고분지형 또는 과분지형 폴리카르보네이트,이의 제법 및 용도
DE102004005652A1 (de) 2004-02-04 2005-08-25 Basf Ag Fließfähige Polyesterformmassen
DE102004010138B4 (de) 2004-02-27 2006-04-06 Heraeus Kulzer Gmbh Verstärkte, pressbare Keramikzusammensetzungen für Dentalzwecke
TW201816844A (zh) 2004-03-25 2018-05-01 日商尼康股份有限公司 曝光裝置、曝光方法、及元件製造方法
EP1756509A4 (en) 2004-04-05 2011-01-05 George C Tunis Iii SHIELD PLATE SYSTEM
DE102004026904A1 (de) 2004-06-01 2005-12-22 Basf Ag Hochfunktionelle, hoch- oder hyperverzweigte Polyester sowie deren Herstellung und Verwendung
RU2297430C2 (ru) 2004-06-24 2007-04-20 Асахи Касеи Кемикалз Корпорейшн Композиция поликарбонатной смолы для применения в производстве субстрата для носителя оптической информации
EP1609818B1 (de) 2004-06-24 2010-03-10 Bayer MaterialScience AG Thermostabilisierte Polycarbonat-Zusammensetzungen
US20060099203A1 (en) 2004-11-05 2006-05-11 Pease Larry R B7-DC binding antibody
EP1612231B1 (de) 2004-07-01 2010-03-24 Bayer MaterialScience AG Inhibierung von katalytisch aktiven Verunreinigungen in Polycarbonat nach dem Schmelzeumesterungsverfahren
MY139705A (en) 2004-07-19 2009-10-30 Basf Ag Mixtures of hyperbranched polyesters with polycarbonates as additive for polyester molding compositions
DE102004035357A1 (de) 2004-07-21 2006-03-16 Basf Ag Kontinuierliches Verfahren zur Herstellung von Polyalkylenarylaten mit hyperverzweigten Polyestern und/oder Polycarbonaten
DE102004038976A1 (de) 2004-08-10 2006-02-23 Basf Ag Fließfähige Polyesterformmassen mit ASA/ABS und SAN
FR2874217B1 (fr) 2004-08-10 2006-10-27 Agronomique Inst Nat Rech Polycarbonate de glycerol - compositions organiques le contenant - procede d'obtention de ces compositions organiques et procede d'extraction du polycarbonate de glycerol et leurs applications
DE102004059243A1 (de) 2004-08-10 2006-02-23 Basf Ag Thermoplastische Formmassen mit verbesserten Fließ- und Entformungseigenschaften
DE102004038979A1 (de) 2004-08-10 2006-02-23 Basf Ag Schlagzähmodifizierte Polyester mit hyperverzweigten Polyestern
WO2014153046A2 (en) 2013-03-14 2014-09-25 Ppg Industries Ohio, Inc. Polyurethanes, articles and coatings prepared therefrom and methods of making the same
DE102004049342A1 (de) 2004-10-08 2006-04-13 Basf Ag Fließfähige Thermoplaste mit halogenfreiem Flammschutz
DE102004050025A1 (de) 2004-10-13 2006-04-20 Basf Ag Fließfähige Thermoplaste mit Halogenflammschutz
DE102004051214A1 (de) 2004-10-20 2006-05-04 Basf Ag Fließfähige Polyoxymethylene
DE102004051241A1 (de) 2004-10-20 2006-05-04 Basf Ag Fließfähige Polyamide mit hyperverzweigten Polyestern/Polycarbonaten
US7140738B2 (en) 2004-11-24 2006-11-28 Cytyc Corporation System and method for calibrating position of microscope slide within storage receptacle
JP2006150500A (ja) 2004-11-29 2006-06-15 Elpida Memory Inc レジンボンド砥石およびそれを用いた半導体チップの製造方法
JP2006160871A (ja) 2004-12-07 2006-06-22 Seikoh Chem Co Ltd 衣料用樹脂組成物
FR2880025B1 (fr) 2004-12-23 2007-03-30 Agronomique Inst Nat Rech Polyesters de polycarbonate de glycerol et d'autres polymeres et copolymeres polyhydroxyles, procede d'acylation et applications
DE102005002119A1 (de) 2005-01-14 2006-07-27 Basf Ag Fließfähige Polyolefine
US7300163B2 (en) 2005-01-21 2007-11-27 Cytyc Corporation Slide misload detection system and method
DE102005004856A1 (de) 2005-02-01 2006-08-03 Basf Ag Fliessfähige Polyester mit Carbodilmid-Stabilisatoren
DE102005009166A1 (de) 2005-02-25 2006-08-31 Basf Ag Hochfunktionelle, hoch- oder hyperverzweigte Polycarbonate sowie deren Herstellung und Verwendung
US7374391B2 (en) 2005-12-22 2008-05-20 Applied Materials, Inc. Substrate gripper for a substrate handling robot
EP3530736A3 (en) 2005-05-09 2019-11-06 ONO Pharmaceutical Co., Ltd. Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
DE102005027549A1 (de) 2005-06-14 2006-12-21 Basf Ag Mehrkomponentenformkörper mit Polyesterschichten
SI1907424T1 (sl) 2005-07-01 2015-12-31 E. R. Squibb & Sons, L.L.C. Humana monoklonska protitelesa proti programiranem smrtnem ligandu 1 (PD-L1)
DE102005032585A1 (de) 2005-07-11 2007-01-25 Basf Ag Verfahren zur Herstellung von Leder
EP1743897A1 (en) 2005-07-15 2007-01-17 Gesellschaft für Biotechnologische Forschung mbH Biologically active compounds obtainable from Sorangium cellulosum
DE102005034999A1 (de) 2005-07-22 2007-01-25 Basf Ag Fließfähige Polyester mit Polyesterelastomeren
DE102005034980A1 (de) 2005-07-22 2007-01-25 Basf Ag Fasern und Flüssigkeitsbehälter aus PET
US20070098997A1 (en) 2005-11-02 2007-05-03 Bayer Materialscience Llc Composite articles and a process for their production
US20070243184A1 (en) 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
WO2007065167A1 (en) 2005-12-02 2007-06-07 The Johns Hopkins University Use of high-dose oxazaphosphorine drugs for treating immune disorders
EP1968698B1 (en) 2005-12-12 2016-11-23 Peters, Tor Intra cardiac device
US7989160B2 (en) 2006-02-13 2011-08-02 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
FR2901164B1 (fr) 2006-05-16 2008-08-15 Aro Soc Par Actions Simplifiee Pince a enserrer des toles, utilisee en association avec un bras manipulateur, et a module d'equilibrage deporte
US7880155B2 (en) 2006-06-15 2011-02-01 Brooks Automation, Inc. Substrate alignment apparatus comprising a controller to measure alignment during transport
US7999940B2 (en) 2006-06-30 2011-08-16 Asml Netherlands B.V. Apparatus for angular-resolved spectroscopic lithography characterization
KR101409607B1 (ko) 2006-07-12 2014-06-18 미쓰비시 가가꾸 가부시키가이샤 폴리우레탄의 제조 방법 및 그것으로부터 얻어진 폴리우레탄의 용도
US20090209701A1 (en) 2006-07-20 2009-08-20 Basf Se, Water-based lacquers comprising highly functional, highly branched or hyperbranched polycarbonates
AU2007281780A1 (en) 2006-08-04 2008-02-14 Ikonisys, Inc. Z-motion microscope slide mount
KR20090077035A (ko) 2006-08-04 2009-07-14 아이코니시스 인코포레이티드 자동 현미경을 위한 자동화된 카세트 및 슬라이드 핸들링 시스템
GB2441594B (en) 2006-09-08 2011-09-07 Thermo Shandon Ltd Hopper for storing coverslips
KR101492278B1 (ko) 2006-10-12 2015-02-11 바스프 에스이 열전도성 폴리에스테르 성형 재료
TW200819421A (en) 2006-10-31 2008-05-01 Univ Nat Chunghsing The method of synthesizing biphenol A, BPA having di-alkoxyl group by using polycarbonate or its waste
CN101573413A (zh) 2006-12-19 2009-11-04 巴斯夫欧洲公司 具有改进延性的热塑性模塑组合物
JP2010513630A (ja) 2006-12-20 2010-04-30 ビーエーエスエフ ソシエタス・ヨーロピア 異方性多孔質エラストマー
KR100800713B1 (ko) 2007-01-29 2008-02-01 삼성전자주식회사 휴대용 단말기
DE502008002134D1 (de) 2007-01-30 2011-02-10 Basf Se Verfahren zur herstellung von polyethercarbonatpolyolen
WO2008147482A2 (en) 2007-02-13 2008-12-04 Northeastern University Methods and compositions for improving immune responses
JP4449998B2 (ja) 2007-03-12 2010-04-14 ヤマハ株式会社 アレイスピーカ装置
US8098956B2 (en) 2007-03-23 2012-01-17 Vantana Medical Systems, Inc. Digital microscope slide scanning system and methods
JP2008311985A (ja) 2007-06-15 2008-12-25 Panasonic Corp 位相調整装置およびデジタルカメラ
DE102007031053A1 (de) 2007-07-04 2009-01-15 Texas Instruments Deutschland Gmbh Integriertes elektronisches Gerät, einschließlich einer Schaltung zur Bereitstellung einer Systemversorgungsspannung von einer Hauptspannungsquelle
DE102007032343A1 (de) 2007-07-11 2009-01-15 Bayer Materialscience Ag Polyurethan- und Polyurethanharnstoffelastomere auf Basis von Polycarbonatpolyolen
US20090028857A1 (en) 2007-07-23 2009-01-29 Cell Genesys, Inc. Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
ES2361649T3 (es) 2007-08-15 2011-06-20 Basf Se Mezclas de poliéster con aplitud a la fluencia mejorada y con buenas propiedades mecánicas.
US7972822B2 (en) 2007-08-17 2011-07-05 Polytechnic Institute Of New York University Enzyme-catalyzed polycarbonate and polycarbonate ester synthesis
US20090057137A1 (en) 2007-08-31 2009-03-05 Midwest Research Institute Synthesizing thin films of lithiated transition metal oxide for use in electrochemical and battery devices
JP4436393B2 (ja) 2007-09-11 2010-03-24 本田技研工業株式会社 ワイパー装置
US8501280B2 (en) 2007-10-09 2013-08-06 Basf Se Use of high-functionality highly branched polyetheramine polyols to coat surfaces
SI2206727T1 (sl) 2007-10-11 2015-06-30 Daiichi Sankyo Company, Limited Protitelo, ki cilja osteoklast - soroden protein Siglec-15
KR20100100891A (ko) 2007-11-19 2010-09-15 바스프 에스이 향상된 냉동/해동 안정성을 갖는 중합체 분산액을 제조하기 위한 고도-분지형 중합체의 용도
ES2648799T3 (es) 2007-11-19 2018-01-08 Basf Se Uso de polímeros altamente ramificados en dispersiones de polímero para pinturas brillantes
DE502008003456D1 (de) 2007-11-20 2011-06-16 Basf Se Verwendung von thermoplastischen formmassen für gid/wit
US8446125B2 (en) 2008-06-20 2013-05-21 Superior Communications, Inc. Vehicle power charger
JP2010013523A (ja) 2008-07-02 2010-01-21 Soft99 Corporation 透明樹脂部材の透明性回復方法および透明性回復用コーティング組成物
US7956285B2 (en) 2008-07-03 2011-06-07 Cooper Technologies Company Floor stand for mounting an electrical box
RS54233B1 (en) 2008-08-25 2015-12-31 Amplimmune Inc. PD-1 ANTAGONIST COMPOSITIONS AND PROCEDURES FOR THEIR APPLICATION
NO2337809T3 (pt) 2008-09-08 2017-12-30
EP2387490B1 (en) 2009-01-14 2015-09-02 Bayer MaterialScience LLC Long-fiber thermoset composite with low orange peel, method for preparing and use of this composite
US20100222524A1 (en) 2009-02-27 2010-09-02 Bayer Materialscience Llc High modulus transparent thermoplastic polyurethanes characterized by high heat and chemical resistance
US8575316B2 (en) * 2009-04-09 2013-11-05 Daiichi Sankyo Company, Limited Anti-Siglec-15 antibody
ATE517149T1 (de) 2009-05-11 2011-08-15 Basf Se Verstärkte styrolcopolymere
CN101633731B (zh) 2009-08-14 2011-08-03 广州市达志化工科技有限公司 一种脂肪族聚碳酸酯多元醇的制备方法
US20120201982A1 (en) 2009-08-18 2012-08-09 Bayer Materialscience Llc Coating compositions for glass substrates
AU2010286351A1 (en) 2009-08-31 2012-03-15 Amplimmune, Inc. B7-H4 fusion proteins and methods of use thereof
EP2299281B1 (en) 2009-09-16 2023-02-15 Sysmex Corporation Rack collecting unit and sample processing apparatus
CZ2009620A3 (cs) 2009-09-22 2011-04-06 Ústav makromolekulární chemie AV CR, v.v.i. Surovina pro výrobu polyurethanu a zpusob její výroby z odpadního polyurethanu
WO2011068826A1 (en) 2009-12-01 2011-06-09 E.I. Du Pont De Nemours And Company Two-component polyurethane coating compositions
WO2011089120A1 (de) 2010-01-20 2011-07-28 Bayer Materialscience Ag Verfahren zur aktivierung von doppelmetallcyanidkatalysatoren zur herstellung von polyethercarbonatpolyolen
CN101775129B (zh) 2010-02-04 2012-06-27 东南大学 一种制备聚醚碳酸酯多元醇的方法
US8530567B2 (en) 2010-02-18 2013-09-10 Basf Se Polymer dispersion which comprises a highly branched polycarbonate having unsaturated fatty acid groups
KR101760242B1 (ko) 2010-03-31 2017-07-21 베링거 인겔하임 인터내셔날 게엠베하 항-ｃｄ40 항체
JP2011221188A (ja) 2010-04-07 2011-11-04 Sony Corp ステージ制御装置、ステージ制御方法及び顕微鏡
EP2558513A1 (en) 2010-04-14 2013-02-20 Dow Global Technologies LLC Polycarbonate polyols and polyurethanes made therefrom
US20110274932A1 (en) 2010-05-05 2011-11-10 Basf Se Component comprising an insert part and plastics jacketing, and process for production of the component
JP2012013952A (ja) 2010-06-30 2012-01-19 Sony Corp ステージ装置及び顕微鏡
WO2012045481A2 (en) 2010-10-05 2012-04-12 Daiichi Sankyo Company, Limited Antibody targeting osteoclast-related protein siglec-15
US20120085961A1 (en) 2010-10-12 2012-04-12 Bayer Materialscience Llc Method for improving sound damping performance for automotive interior applications
EP2644698B1 (en) * 2010-11-17 2018-01-03 Chugai Seiyaku Kabushiki Kaisha Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
EP2643374B1 (en) 2010-11-23 2019-09-18 Saudi Aramco Technologies Company Polycarbonate polyol compositions
DE102010061167B3 (de) 2010-12-10 2012-05-31 Leica Microsystems Cms Gmbh Mikroskoptisch
WO2012085132A1 (en) * 2010-12-22 2012-06-28 Orega Biotech Antibodies against human cd39 and use thereof
CN102206333B (zh) 2011-04-18 2013-12-04 中科院广州化学有限公司 一种低分子量聚碳酸酯多元醇及其制备方法和用途
LT2699264T (lt) 2011-04-20 2018-07-10 Medimmune, Llc Antikūnai ir kitos molekulės, kurios jungiasi prie b7-h1 ir pd-1
CZ303628B6 (cs) 2011-06-06 2013-01-16 Ústav makromolekulární chemie AV CR, v.v.i. Smes polyolu a zpusob její prípravy
CN102382441A (zh) 2011-06-17 2012-03-21 珠海市远康企业有限公司 光学高透聚碳酸酯材料及其制备方法
EP2548906A1 (de) 2011-07-18 2013-01-23 Bayer MaterialScience AG Verfahren zur Aktivierung von Doppelmetallcyanidkatalysatoren zur Herstellung von Polyetherpolyolen
EP2548907A1 (de) 2011-07-18 2013-01-23 Bayer MaterialScience AG Verfahren zur Herstellung von Polyetherpolyolen
US8790651B2 (en) * 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
ES2908046T3 (es) 2011-09-09 2022-04-27 Medimmune Ltd Anticuerpos anti-siglec-15 y usos de los mismos.
EP2832855A4 (en) 2012-03-30 2016-02-24 Daiichi Sankyo Co Ltd NEW ANTI-SIGLEC ANTIBODY-15
JP5911365B2 (ja) 2012-04-20 2016-04-27 オリンパス株式会社 複合型顕微鏡
US20150138632A1 (en) 2012-05-18 2015-05-21 Huron Technologies International Inc. Slide tray and receptor for microscopic slides and method of operation
ES2723885T3 (es) 2012-07-19 2019-09-03 Daiichi Sankyo Co Ltd Anticuerpos anti-Siglec-15
CN102911636B (zh) 2012-09-26 2013-12-18 贵阳时代沃顿科技有限公司 一种双组分聚氨酯胶粘剂及其制备方法和应用
CN109021209A (zh) 2012-11-07 2018-12-18 沙特阿美技术公司 高强度聚氨酯泡沫组合物及方法
SG11201502736YA (en) 2012-11-09 2015-05-28 Bayer Materialscience Ag Method for producing polyether carbonate polyols
EP2931798B1 (en) 2012-12-14 2019-10-16 Resinate Materials Group, Inc. Reaction products containing hydroxyalkylterephthalates and methods of making and using same
US9001422B2 (en) 2013-02-28 2015-04-07 Ventana Medical Systems, Inc. Slide handling system and techniques
US20140362436A1 (en) 2013-06-07 2014-12-11 Clemex Technologies Inc. Automatic slide loading system and method
JP5835273B2 (ja) 2013-06-13 2015-12-24 コニカミノルタ株式会社 熱可塑性樹脂組成物
EP3010970B1 (en) 2013-06-21 2019-09-18 SABIC Global Technologies B.V. Polycarbonate composition to produce optical quality products with high quality and good processability
EP2851384A1 (de) 2013-09-20 2015-03-25 Bayer MaterialScience AG Verzweigte Polyethercarbonatpolyole und Verfahren zu deren Herstellung
EP3077437A1 (de) 2013-11-27 2016-10-12 Covestro Deutschland AG Mischungen von polyethercarbonatpolyolen und polyetherpolyolen zur herstellung von polyurethanweichschaumstoffen
ES2658301T3 (es) 2014-02-26 2018-03-09 Covestro Deutschland Ag Procedimiento para la preparación de polieterestercarbonatopolioles
EP2915808A1 (en) 2014-03-07 2015-09-09 Construction Research & Technology GmbH 2-Hydroxyethyl 2-oxo-1,3-dioxolane-4-carboxylates, their preparation and use
CN104004179A (zh) 2014-04-19 2014-08-27 上海东大化学有限公司 废旧回收物制备聚醚多元醇、硬泡聚氨酯的方法及产物
WO2015171432A1 (en) 2014-05-05 2015-11-12 Resinate Materials Group, Inc. Improved recycle-content polyester polyols
US11300769B2 (en) 2014-05-29 2022-04-12 Rarecyte, Inc. Automated substrate loading
US10890748B2 (en) 2014-05-29 2021-01-12 Rarecyte, Inc. Automated substrate loading
US10802260B2 (en) 2014-05-29 2020-10-13 Rarecyte, Inc. Automated substrate loading
US11422352B2 (en) 2014-05-29 2022-08-23 Rarecyte, Inc. Automated substrate loading
CN106415356B (zh) 2014-05-29 2019-03-26 瑞尔赛特股份有限公司 用来将基板保持在二级装置内的设备
US20180003939A1 (en) 2014-05-29 2018-01-04 Rarecyte, Inc. Apparatus for holding a substrate within a secondary device
TWI653701B (zh) 2014-06-09 2019-03-11 日商荏原製作所股份有限公司 Substrate attaching and detaching portion for substrate holder, wet substrate processing device including the substrate attaching and detaching portion, substrate processing device, and substrate transfer method
CN104163976A (zh) 2014-06-09 2014-11-26 江苏欣润塑胶有限公司 一种抗菌防霉塑胶
JP2017523148A (ja) 2014-06-18 2017-08-17 第一三共株式会社 骨形成不全症の治療に使用するための抗Ｓｉｇｌｅｃ−１５抗体
AU2015279191B2 (en) 2014-06-27 2018-07-26 F. Hoffmann-La Roche Ag Automated specimen processing systems and methods of detecting specimen-bearing microscope slides
CN104119486B (zh) 2014-06-27 2017-02-08 重庆阮氏塑业有限公司 一种聚碳酸酯复合材料及其制备方法
US10018056B2 (en) 2014-07-02 2018-07-10 United Technologies Corporation Abrasive coating and manufacture and use methods
EP3164443B1 (de) 2014-07-03 2018-10-31 Covestro Deutschland AG Verfahren zur reinigung von polycarbonatpolyolen und reinigungsvorrichtung hierfür
AU2015301972B2 (en) 2014-08-11 2019-01-17 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane with high heat resistance
ES2907387T3 (es) 2014-08-11 2022-04-25 Lubrizol Advanced Mat Inc Poliuretano termoplástico de transmisión de vapor húmedo con alta resistencia al calor
EP3183286A4 (en) 2014-08-20 2018-08-22 Resinate Materials Group, Inc. Polyester polyols from recycled polymers and waste streams
US20170335057A1 (en) 2014-10-29 2017-11-23 Resinate Materials Group, Inc. High recycle content polyester polyols from hydroxy-functional ketal acids, esters or amides
CN104356634A (zh) 2014-11-07 2015-02-18 苏州蔻美新材料有限公司 一种除臭透气医用膜及其制备方法
CN104610872A (zh) 2015-01-28 2015-05-13 芜湖县双宝建材有限公司 一种耐水耐老化水性聚氨酯涂料
US9522976B2 (en) 2015-03-20 2016-12-20 Resinate Materials Group, Inc. Cycloaliphatic polyester polyols from thermoplastic polyesters
JP2018522090A (ja) 2015-05-21 2018-08-09 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ エネルギー硬化性超分岐ポリカーボネートポリオール骨格多官能アクリレート
EP3298065A4 (en) 2015-05-21 2019-02-27 Basf Se PREPARATION OF HYPER BRANCHED POLYCARBONATE POLYOLS AND THEIR USE
JP6341888B2 (ja) 2015-07-02 2018-06-13 大日精化工業株式会社 ポリヒドロキシウレタン樹脂及びその製造方法
CN105174822A (zh) 2015-08-18 2015-12-23 苏州赛斯德工程设备有限公司 一种建筑外墙自保温材料的制备方法
TW201729841A (zh) 2015-11-10 2017-09-01 耶魯大學 用於治療自體免疫疾病及癌症之組成物及方法
CN106008948B (zh) 2016-06-20 2018-05-15 广州财睿投资咨询有限责任公司 一种基于生物质的聚碳酸酯多元醇和制备方法及其聚氨酯
JP7002254B2 (ja) 2016-09-13 2022-01-20 中国塗料株式会社 スラブ式軌道の補修材料、硬化体、スラブ式軌道の補修方法、スラブ式軌道および樹脂組成物
CN110035769A (zh) 2016-09-21 2019-07-19 奈斯科尔公司 针对siglec-15的抗体及其使用方法
JP6944099B2 (ja) 2016-09-21 2021-10-06 株式会社山根商店 洗浄具
CN108070067A (zh) 2016-11-15 2018-05-25 中国科学院青岛生物能源与过程研究所 一种可交联型涂层用抗菌聚氨酯的制备方法
WO2018140073A1 (en) 2017-01-27 2018-08-02 Rarecyte, Inc. Automated substrate loading
US10053533B1 (en) 2017-04-13 2018-08-21 Presidium Usa, Inc. Oligomeric polyol compositions
CN110218257A (zh) 2019-06-24 2019-09-10 王跃驹 植物作为宿主在表达Antis15抗体中的应用

Also Published As

Publication number Publication date
EP3515478A1 (en) 2019-07-31
KR20190050816A (ko) 2019-05-13
JP2024020298A (ja) 2024-02-14
RU2019111722A3 (pt) 2020-12-21
WO2018057735A8 (en) 2018-06-07
AU2017330346A1 (en) 2019-02-21
US11390675B2 (en) 2022-07-19
EP3515478B1 (en) 2024-02-28
RU2759334C2 (ru) 2021-11-12
CN110035769A (zh) 2019-07-19
KR20240035625A (ko) 2024-03-15
US20190202912A1 (en) 2019-07-04
RU2019111722A (ru) 2020-10-22
CA3033571A1 (en) 2018-03-29
EP3515478A4 (en) 2020-07-15
WO2018057735A1 (en) 2018-03-29
DK3515478T3 (da) 2024-05-21
KR102644544B1 (ko) 2024-03-11
JP2019536470A (ja) 2019-12-19
JP7382444B2 (ja) 2023-11-16
JP7069177B2 (ja) 2022-05-17
JP2022126630A (ja) 2022-08-30

Similar Documents

Publication Publication Date Title
BR112019005292A2 (pt) anticorpos para siglec-15 e métodos de uso dos mesmos.
CL2018001326A1 (es) Proteínas de unión a ctla4.
BR112018001530A2 (pt) anticorpo biespecífico, polinucleotídeo, vetor, célula hospedeira, métodos para produzir o anticorpo biespecífico e de inibição do crescimento de células tumorais e composição farmacêutica
EA201692504A1 (ru) Триспецифичные связывающие молекулы и способы их применения
UY36536A (es) Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
MX2020004129A (es) Anticuerpos anti-cd38 y metodos de uso.
MX2019009817A (es) Anticuerpos anti-tau y metodos de uso de los mismos.
BR112018071307A2 (pt) anticorpos agonistas que ligam cd40 humana e usos dos mesmos
BR112018002844A2 (pt) receptores de antígeno quimérico à base de anticorpos de domínio único e métodos de uso dos mesmos
BR112016022841A8 (pt) Anticorpo igm, iga, igg / igm ou igg / iga, ou um fragmento de ligação ao antígeno do mesmo, composição que o compreende e uso do mesmo
BR112018012113A2 (pt) anticorpos monoclonais de ctla4 anti-humana quiméricos e humanizados e usos dos mesmo
PE20181046A1 (es) Anticuerpos anti-tigit y metodos de uso
BR112017025529A2 (pt) agentes de ligação ao tigit e usos destes
BR112019011186A2 (pt) conjugado de anticorpo radiomarcado, composto, e, métodos de imageamento e para tratamento de um tumor.
EA202190542A1 (ru) Сконструированные биспецифические белки
BR112015007672A2 (pt) anticorpos anti-pd-l1 monoclonais humanos e métodos de uso
BR112017002646A2 (pt) proteínas de fusão da imunoglobulina sirp-alfa
BR112014008382A2 (pt) anticorpo especificamente ligando a epítope no domínio sema do c-met
EA201891709A1 (ru) Антигенсвязывающие белки, связывающие pd-l1
CL2019000119A1 (es) Proteínas de unión de tipo anticuerpo biespecíficas que se unen específicamente a cd3 y cd123.
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
EA202091350A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
BR112021012667A2 (pt) Proteínas de ligação anti-pd-1 e métodos de uso destas
EA201992281A1 (ru) Связывающие молекулы, специфично связывающиеся с тау-белком
MX2022009915A (es) Anticuerpos anti-ror2, fragmentos de anticuerpos, sus inmunoconjugados y usos de los mismos.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]